A few years ago, this supplement was not available to the general public because the Food and Drug Administration did not approve of it for use on the skin
Patients who've used both report no perceptible difference in side effect profile or appetite suppression when dose and injection timing are matched
A spreadsheet, notebook, or smartphone app that records daily or weekly measurements over time reveals trends invisible in individual readings
These medications work by activating GLP-1 receptors in the brain and pancreas, reducing appetite, slowing gastric emptying, and improving glycemic control
Potential for Synergy: The hope is that the effects of combining tesamorelin and retatrutide might be synergistic, meaning the combined effect is greater than the sum of their individual parts
This log will provide valuable insights for you and your doctor, helping to identify patterns and make adjustments to your tapering plan before issues arise